We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
In this new role, Professor George will lead the Agency’s science strategy and will oversee the MHRA’s scientific, research and innovation activities.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
Residential Property Tribunal Decision of Judge Prof R Percival and Mr S Wheeler MCIEH, CEnvH dated 11 November 2024.
Summary of the latest safety advice for medicines and medical device users
The authors of this review sought to identify every study where people with an abdominal injury were randomised to surgery or observation
As with any medicine, the MHRA will keep the safety and effectiveness of Nirogacestat hydrobromide under close review.
Information and resources on musculoskeletal health conditions.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).